Cargando…

Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India

Introduction Prescription pattern studies conducted in patients with schizophrenia have shown variability in the utilization of antipsychotics based on the geographical location of the study setting. Moreover, there is only a sparse number of studies specifically related to adverse drug reactions (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathi, Raakhi K, Gajbhiye, Snehalata, Jalgaonkar, Sharmila, Khatri, Nishtha, Sayyed, Mohsin, Parkar, Shubhangi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033527/ https://www.ncbi.nlm.nih.gov/pubmed/35481315 http://dx.doi.org/10.7759/cureus.23378

Ejemplares similares

A Cross-Sectional, Questionnaire-Based Study on Drug Treatment Awareness in Schizophrenia Patients and Caregivers: An Unexplored Avenue
por: Tripathi, Raakhi, et al.
Publicado: (2021)

Evaluation of Antidepressant Effect of Minocycline in Alcohol Abstinence-Induced Depression Model in Mice
por: Gajbhiye, Snehalata, et al.
Publicado: (2022)

Critical appraisal of published research papers – A reinforcing tool for research methodology: Questionnaire-based study
por: Gajbhiye, Snehalata, et al.
Publicado: (2021)

A Retrospective Study of Ethics Committee Monitoring Checklists of the Audiovisual Consent Process: An Ethical Perspective
por: Shetty, Yashashri C, et al.
Publicado: (2023)

Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students
por: Tripathi, Raakhi Kaliprasad, et al.
Publicado: (2016)

Perception of postgraduate students in pharmacology toward animal simulation model
por: Jalgaonkar, Sharmila V., et al.
Publicado: (2019)

Drug use pattern for emergency psychiatric conditions in a tertiary care hospital: A prospective observational study
por: Jalgaonkar, Sharmila V., et al.
Publicado: (2021)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Brain Networks Reveal the Effects of Antipsychotic Drugs on Schizophrenia Patients and Controls
por: Towlson, Emma K., et al.
Publicado: (2019)

Association of Serotonin(2c) Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia
por: Li, Jiang, et al.
Publicado: (2019)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
por: Hori, Hikaru, et al.
Publicado: (2022)

Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics
por: Minjon, Lenneke, et al.
Publicado: (2021)

Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis
por: Valencia Carlo, Yarmila Elena, et al.
Publicado: (2023)

Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment
por: Nelson, Eric A., et al.
Publicado: (2018)

The Pharmacodynamics of Antipsychotic Drugs in Women and Men
por: Seeman, Mary V.
Publicado: (2021)

An Audit of Protocol Deviations Submitted to an Institutional Ethics Committee of a Tertiary Care Hospital
por: Jalgaonkar, Sharmila V., et al.
Publicado: (2016)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
por: Kornetova, Elena G., et al.
Publicado: (2019)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
por: Koricanac, Aleksandra, et al.
Publicado: (2022)

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
por: Boyda, Heidi N., et al.
Publicado: (2020)

Antipsychotic Drug Development: From Historical Evidence to Fresh Perspectives
por: Weston-Green, Katrina
Publicado: (2022)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
por: Khasawneh, Fadi T., et al.
Publicado: (2014)

The story of antipsychotics: A metaphorical overview
por: Khatri, Nishtha
Publicado: (2019)

Recent Advances in Understanding and Mitigating Adipogenic and Metabolic Effects of Antipsychotic Drugs
por: Gohlke, Julia M., et al.
Publicado: (2012)

Antipsychotics-induced improvement of cool executive function in individuals living with schizophrenia
por: Si, Yajing, et al.
Publicado: (2023)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
por: Rampino, Antonio, et al.
Publicado: (2019)

Schizophrenia treatment with a combination of two LAI antipsychotics: A case report
por: Jarosz, Marcin, et al.
Publicado: (2022)

Comparative effectiveness of antipsychotic drugs in schizophrenia
por: Stroup, T. Scott, et al.
Publicado: (2000)

Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report
por: Izuhara, Muneto, et al.
Publicado: (2018)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
por: Yu, Zhi-min, et al.
Publicado: (2019)

Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia
por: Nicoletti, Ferdinando, et al.
Publicado: (2019)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Hjorth, Stephan
Publicado: (2021)

Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia
por: Bugarski-Kirola, Dragana, et al.
Publicado: (2022)

Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study
por: Cicala, Giuseppe, et al.
Publicado: (2020)

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
por: Zhang, Xiaobin, et al.
Publicado: (2020)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Yin, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gv386lgjf64531lo5vma1cg6r8